Tag Archives: Immunocore

Target Validation- Single Cell RNA sequencing Immunocore Limited, just south of Oxford, UK, is an innovative and dynamic biotechnology company developing a unique platform of T Cell antigen receptor-based therapeutics, called ImmTACs, as a novel class of treatments for cancer. ...

Read More »